Individualising Anticoagulant Therapy in Atrial Fibrillation Patients

about

Individualising Anticoagulant Therapy in Atrial Fibrillation Patients

Item

http://www.wikidata.org/entity/Q37235927

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Individualising Anticoagulant Therapy in Atrial Fibrillation Patients

@en

Individualising Anticoagulant Therapy in Atrial Fibrillation Patients.

@nl

type

Item

label

Individualising Anticoagulant Therapy in Atrial Fibrillation Patients

@en

Individualising Anticoagulant Therapy in Atrial Fibrillation Patients.

@nl

prefLabel

Individualising Anticoagulant Therapy in Atrial Fibrillation Patients

@en

Individualising Anticoagulant Therapy in Atrial Fibrillation Patients.

@nl

P1476

Individualising Anticoagulant Therapy in Atrial Fibrillation Patients

@en

P2093

Marco Alings

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Idarucizumab: The Antidote for Reversal of Dabigatran

Efficacy and Harms of Direct Oral Anticoagulants in the Elderly for Stroke Prevention in Atrial Fibrillation and Secondary Prevention of Venous Thromboembolism: Systematic Review and Meta-Analysis

Emergency hospitalizations for adverse drug events in older Americans

Dabigatran versus warfarin in patients with atrial fibrillation

Idarucizumab for Dabigatran Reversal

Epidemiology of atrial fibrillation: European perspective

Heart disease and stroke statistics--2012 update: a report from the American Heart Association

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

P304

102-109

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.15420/AER.2016.20.3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27617088

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

atrial fibrillation

P932

5013151

http://www.w3.org/2001/XMLSchema#string